2.3450.21% ( +0.005 )
Delay Closed: Nov 16, 16:08:11Overview
FUDANZHANGJIANG (1349)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of biopharmaceutical products in the People's...
- Open
- 2.430
- High
- 2.450
- Low
- 2.305
- Prev. Close
- 2.340
- Volume
- 775.00K
- Turnover
- 1.82M
- Avg Price
- 2.346
- Bid/Ask Ratio
- 60.00%
- Amplitude
- 6.20%
- 52wk High
- 3.690
- Volume Ratio
- 0.60
- Turnover Ratio
- 0.24%
- 52wk Low
- 2.200
- HK Mkt Cap
- 764.47M
- Market CapHKD
- 2.43B
- P/ETTM
- Loss
- P/EDynamic
- 40.74
- P/EStatic
- --
- EPSTTM
- -0.116
- EPSDynamic
- 0.0576
- EPSStatic
- --
- BVPS
- 2.42
- P/B
- 0.97
- HK Shares
- 326.00M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 1.04B
- Min lot size
- 1,000
- Currency
- HKD
FUDANZHANGJIANG Analyst Rating
View moreForecast & Rating
Aug 21, 2019Price forecast
HK$6.50177.13%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
Market Movers · Fudan-Zhangjiang climbs 5%
Tip Ranks · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Sets Board Meeting to Approve Nine-Month Results
Tip Ranks · Shanghai Fudan Zhangjiang Bio Pharmaceutical Places RMB210 Million in SPD Bank Structured Deposit
Tip Ranks · Fudan Zhangjiang Invests RMB150 Million in Low-Risk Bank of China Structured Deposit
Tip Ranks · Fudan-Zhangjiang Clarifies Connected Transactions in 2025 Annual Report
Global Report · Hong Kong's Divergent Paths: AI Supply Chain Windfalls and Real Estate Reckonings
